Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Teopompi, G. Pisi, M. Aiello, R. Pisi, P. Mangano, F. Longo, P. Rizè, C. Tripodi, V. Fainardi, E. Clini, A. Chetta, A. Sala (Parma, Milan, Modena, Italy). Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults With cystic fibrosis?. Eur Respir J 2013; 42: Suppl. 57, 2112

Member's Comments

No comment yet.

Related content which might interest you: Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Source: Eur Respir J 2015; 46: 1033-1045 Year: 2015 Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 Dropping acid: why is cystic fibrosis mucus abnormal? Source: Eur Respir J, 52 (6) 1802057; 10.1183/13993003.02057-2018 Year: 2018 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Differential actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA in macrophages and bronchial epithelial cells Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007 Nasal NO in cystic fibrosis is associated with CFTR genotype, pseudomonas colonization and fatty acids Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Nutritional intervention in cystic fibrosis Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153 Year: 2003 Bile acid aspiration in people with cystic fibrosis before and after lung transplantation Source: Eur Respir J 2015; 46: 1820-1823 Year: 2015 LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD Source: Eur Respir J 2016; 47:1645-1656 Year: 2016 The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Oleanolic acid acetate ameliorates bleomycin-induced pulmonary fibrosis through inhibition of epithelial-mesenchymal transition Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019